FOLR1 and neoplasm: Ao at al. further verified that the anti-FRα CARs redirect NK-92 cells with specific anti-tumour activity, and the third-generation anti-FRα CAR-engineered NK-92 cells display more potent cytotoxicity against FRα-positive OC [81].